Effects of prostaglandin E2 on growth, morphology, morphometry and keratin pattern of bovine corneal epithelial cells cultured in vitro.
In this work the relationship between the proliferation of bovine corneal epithelial cells and PGE2 has been studied. Our data indicate that PGE2 plays an important role in the growth of corneal epithelial cells. Actually, epithelial cells cultured on a keratocyte feeder-layer and exposed to indomethacin, a cyclooxygenase inhibitor, have shown a decrease in growth rate at drug concentrations which otherwise did not induce a reduction in the viability of the keratocytes as well as in epithelial cells in separate cultures. This effect has been reversed by an exogenous PGE2 addition to the culture media. Moreover, significant increases have been found in the growth of epithelial cells cultured in the presence of keratocytes, with basal medium and with conditioning medium after adding exogenous PGE2 at concentrations equal to or lower than 10(-6) M. Significant decreases in the dimensions of the corneal epithelial cells have been found only when PGE2 has been added to basal and to conditioning medium, suggesting that the autacoid maintains cell dimension and morphology. The appearance of keratins with high molecular weight (54 and 57 kDa) coupled with the tendency to stratification of the cells cultivated with media supplemented with PGE2, indicates that the autacoid could favour cell differentiation. The action of PGE2 on the corneal epithelial cells does not seem to be influenced by the presence of the fibroblasts and their products, since PGE2 has induced increases in cell growth and morphological variations, independent of cultural conditions and therefore also only in the presence of basal medium.
Parnigotto
P P
PP
Interdepartmental Centre for the Study of Keratinocytes: Pharmaceutical and Clinical Applications, University of Padua, Italy.
Conconi
M T
MT
D000818:Animals; D002417:Cattle; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D018920:Coculture Techniques; D003239:Connective Tissue Cells / Q000166:cytology / Q000502:physiology; D003315:Cornea / Q000166:cytology / Q000502:physiology; D017077:Culture Media, Conditioned; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D015232:Dinoprostone / Q000494:pharmacology*; D019573:Epithelium, Corneal / Q000166:cytology* / Q000187:drug effects / Q000648:ultrastructure; D007213:Indomethacin / Q000494:pharmacology; D007633:Keratins / Q000378:metabolism*; D007700:Kinetics; D008855:Microscopy, Electron, Scanning
D017077:Culture Media, Conditioned; D016861:Cyclooxygenase Inhibitors; D007633:Keratins; D015232:Dinoprostone; D007213:Indomethacin